|
Jun 20
|
Innocan Pharma Announces Presentation of Narrative Review on Long-Acting Synthetic Cannabidiol for Chronic Pain at PAINWEEK Conference
|
|
Dec 31
|
Innocan Pharma Announces Closing of Private Placement for Gross Proceeds of C$635,444.60
|
|
Dec 19
|
Innocan Pharma Announces Private Placement of Units
|